Tandem Diabetes Care, Inc.
TNDMFinancial Statements
Income Statement (Annual)
Amounts in millions
2024
12/31/2024
Revenue
940
Cost of Revenue
451
Gross Profit
490
Gross Margin
52.1%
Operating Income
-99
Operating Margin
-10.5%
Net Income
-96
Net Margin
-10.2%
EPS (Basic)
$-1.47
EPS (Diluted)
$-1.47
EBITDA
-99
EBITDA Margin
-10.5%
2023
12/31/2023
Revenue
748
Cost of Revenue
380
Gross Profit
368
Gross Margin
49.2%
Operating Income
-233
Operating Margin
-31.2%
Net Income
-223
Net Margin
-29.8%
EPS (Basic)
$-3.43
EPS (Diluted)
$-3.43
EBITDA
-196
EBITDA Margin
-26.3%
2022
12/31/2022
Revenue
801
Cost of Revenue
388
Gross Profit
413
Gross Margin
51.5%
Operating Income
-93
Operating Margin
-11.6%
Net Income
-95
Net Margin
-11.8%
EPS (Basic)
$-1.47
EPS (Diluted)
$-1.47
EBITDA
-74
EBITDA Margin
-9.3%
2021
12/31/2021
Revenue
703
Cost of Revenue
327
Gross Profit
376
Gross Margin
53.5%
Operating Income
23
Operating Margin
3.2%
Net Income
16
Net Margin
2.2%
EPS (Basic)
$0.25
EPS (Diluted)
$0.24
EBITDA
34
EBITDA Margin
4.8%
2020
12/31/2020
Revenue
499
Cost of Revenue
238
Gross Profit
261
Gross Margin
52.2%
Operating Income
-8
Operating Margin
-1.6%
Net Income
-34
Net Margin
-6.9%
EPS (Basic)
$-0.56
EPS (Diluted)
$-0.56
EBITDA
-13
EBITDA Margin
-2.6%